Last $45.33 USD
Change Today +0.42 / 0.94%
Volume 46.5K
CNMD On Other Exchanges
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

conmed corp (CNMD) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/19/14 - $50.47
52 Week Low
08/14/14 - $35.85
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CONMED CORP (CNMD)

conmed corp (CNMD) Related Bloomberg News

View More Bloomberg News

conmed corp (CNMD) Related Businessweek News

No Related Businessweek News Found

conmed corp (CNMD) Details

CONMED Corporation provides surgical devices and equipment for minimally invasive procedures and monitoring. It offers sports medicine products, including powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bioabsorbable implants, and related disposable products and fluid management systems; powered surgical instruments for use in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; electrosurgical generators and related instruments; and 2D and 3D video systems for use in minimally invasive orthopedic and general surgeries. The company also provides patient monitoring products comprising vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, ECG electrodes and cables, cardiac defibrillation and pacing pads, and blood pressure cuffs; surgical suction instruments and tubing products; and IV products used in critical care areas. In addition, it offers endomechanical instrumentation products, such as trocars, clip appliers, scissors, and surgical staplers used in the minimally invasive laparoscopic and gynecological surgery. Further, the company provides gastrointestinal and pulmonary products consisting of minimally invasive diagnostic and therapeutic products, including mucosal management devices, forceps, scope management accessories, bronchoscopy devices, dilatation, stricture management devices, hemostasis, biliary devices, and polypectomy. Its products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company operates in the United States, Canada, the United Kingdom, Japan, Australia, and internationally. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

3,600 Employees
Last Reported Date: 02/24/14
Founded in 1970

conmed corp (CNMD) Top Compensated Officers

Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $320.8K
Chief of Commercial Operations, Executive Vic...
Total Annual Compensation: $371.9K
Principal accounting Officer, Executive Vice ...
Total Annual Compensation: $316.9K
General Counsel and Executive Vice President ...
Total Annual Compensation: $290.6K
Compensation as of Fiscal Year 2013.

conmed corp (CNMD) Key Developments

CONMED Corporation Announces Management Transitions

CONMED Corporation announced a number of management transitions. After 25 years of service, Robert D. Shallish, Jr., Executive Vice President, Finance and Chief Financial Officer, recently informed the Company of his plan to retire on March 31, 2015. Luke Pomilio, Controller, has been appointed Executive Vice President, Finance and Chief Financial Officer of the Company, effective April 1, 2015. The Company also announced that Patrick Beyer, former CEO of ICNet and former head of Stryker Europe, has been appointed President of CONMED International, effective immediately. John Hamilton, Vice President of CONMED International, will retire from the Company effective February 28, 2015. The Company also announced that Joseph Darling will be leaving the Company following the elimination of his position as Executive Vice President, Commercial Operations effective December 31, 2014. Mr. Darling's responsibilities will be realigned and redistributed to senior executives within the CONMED organization.

CONMED Corporation Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 02:30 PM

CONMED Corporation Presents at 26th Annual Piper Jaffray Healthcare Conference, Dec-02-2014 02:30 PM. Venue: The New York Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Robert D. Shallish, Chief Financial Officer and Executive Vice President of Finance.

CONMED Corporation Declares Quarterly Cash Dividend, Payable on January 5, 2015

CONMED Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2015 to all shareholders of record as of December 15, 2014. Annualized, the dividend rate is equivalent to $0.80 per share, yielding approximately 2.0% at current share prices.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CNMD:US $45.33 USD +0.42

CNMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Integra LifeSciences Holdings Corp $53.68 USD +0.32
Masimo Corp $26.60 USD +0.04
NuVasive Inc $47.37 USD +0.78
Paramount Bed Holdings Co Ltd ¥3,215 JPY -75.00
Wright Medical Group Inc $26.65 USD -0.02
View Industry Companies

Industry Analysis


Industry Average

Valuation CNMD Industry Range
Price/Earnings 40.6x
Price/Sales 1.7x
Price/Book 2.1x
Price/Cash Flow 40.1x
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONMED CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at